Scholarlink

Objectives <p>Trimethylamine N-oxide (TMAO) has been implicated in systemic inflammatory pathways, emphasizing its potential as a biomarker. Elevated plasma TMAO levels have been associated with increased oxidative stress, leading to higher plasma concentrations of TNF-α, a key pro-inflammatory cytokine. Given this systemic inflammatory linkage, saliva—a non-invasive diagnostic medium—offers a unique opportunity to reflect both local and systemic inflammatory changes. This study aimed to evaluate the alterations in salivary and serum TMAO levels in periodontitis and assess the diagnostic potential of salivary TMAO as an indicator of periodontal inflammation.</p> Materials and methods <p>Twenty-four patients with periodontitis (Stage III Grade B) and 24 healthy controls were included. Clinical parameters (probing depth (PD), plaque index (PI), bleeding on probing (BOP), and clinical attachment loss (CAL)) were recorded. TMAO levels in saliva and serum were measured using liquid chromatography-mass spectrometry (LC–MS/MS), and TNF-α levels were assessed using Enzyme-Linked ImmunoSorbent Assay (ELISA).</p> Results <p>Salivary and serum TMAO levels and salivary TNF-α levels were significantly higher in the periodontitis group (<i>p</i> = 0.003, <i>p</i> = 0.004, and <i>p</i> = 0.031, respectively). Salivary TMAO showed positive correlations with periodontal parameters (<i>p</i> &lt; 0.05) and salivary TNF-α levels. A significant positive correlation was also observed between salivary and serum TMAO levels (<i>p</i> &lt; 0.001). Salivary TMAO was the accurate biomarker in differentiating between periodontitis and controls (sensitivity = 0.583, specificity = 0.833, AUC = 0.747).</p> Conclusions <p>Salivary TMAO demonstrates potential as a non-invasive marker for periodontitis, showing correlations with clinical parameters and inflammatory markers. These findings suggest that TMAO may reflect both local and systemic inflammatory states associated with periodontal disease.</p> Clinical relevance <p>Salivary TMAO may serve as a potential non-invasive indicator of periodontitis, as it reflects aspects of both local and systemic inflammation, offering insights into periodontal disease status.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Salivary trimethylamine N-oxide: a novel non-invasive marker for periodontal inflammation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月25日

查看全文
  • Ceyhan C. Serdar,
  • Zeliha Guney,
  • Nur Balci,
  • Sema M. Altingoz,
  • Muhittin A. Serdar,
  • Sivge Kurgan

摘要

Objectives

Trimethylamine N-oxide (TMAO) has been implicated in systemic inflammatory pathways, emphasizing its potential as a biomarker. Elevated plasma TMAO levels have been associated with increased oxidative stress, leading to higher plasma concentrations of TNF-α, a key pro-inflammatory cytokine. Given this systemic inflammatory linkage, saliva—a non-invasive diagnostic medium—offers a unique opportunity to reflect both local and systemic inflammatory changes. This study aimed to evaluate the alterations in salivary and serum TMAO levels in periodontitis and assess the diagnostic potential of salivary TMAO as an indicator of periodontal inflammation.

Materials and methods

Twenty-four patients with periodontitis (Stage III Grade B) and 24 healthy controls were included. Clinical parameters (probing depth (PD), plaque index (PI), bleeding on probing (BOP), and clinical attachment loss (CAL)) were recorded. TMAO levels in saliva and serum were measured using liquid chromatography-mass spectrometry (LC–MS/MS), and TNF-α levels were assessed using Enzyme-Linked ImmunoSorbent Assay (ELISA).

Results

Salivary and serum TMAO levels and salivary TNF-α levels were significantly higher in the periodontitis group (p = 0.003, p = 0.004, and p = 0.031, respectively). Salivary TMAO showed positive correlations with periodontal parameters (p < 0.05) and salivary TNF-α levels. A significant positive correlation was also observed between salivary and serum TMAO levels (p < 0.001). Salivary TMAO was the accurate biomarker in differentiating between periodontitis and controls (sensitivity = 0.583, specificity = 0.833, AUC = 0.747).

Conclusions

Salivary TMAO demonstrates potential as a non-invasive marker for periodontitis, showing correlations with clinical parameters and inflammatory markers. These findings suggest that TMAO may reflect both local and systemic inflammatory states associated with periodontal disease.

Clinical relevance

Salivary TMAO may serve as a potential non-invasive indicator of periodontitis, as it reflects aspects of both local and systemic inflammation, offering insights into periodontal disease status.